Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet, High-Fat | 7 | 2020 | 54 | 3.570 |
Why?
|
| Nicotine | 11 | 2021 | 89 | 3.460 |
Why?
|
| Apoptosis | 10 | 2020 | 162 | 2.640 |
Why?
|
| Electronic Nicotine Delivery Systems | 5 | 2020 | 36 | 2.470 |
Why?
|
| Oxidative Stress | 11 | 2020 | 102 | 2.130 |
Why?
|
| Fatty Liver | 5 | 2019 | 53 | 1.940 |
Why?
|
| Myocytes, Cardiac | 4 | 2020 | 26 | 1.800 |
Why?
|
| Animals | 28 | 2023 | 1238 | 1.490 |
Why?
|
| Male | 26 | 2020 | 1649 | 1.300 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 185 | 1.190 |
Why?
|
| Mice, Obese | 4 | 2020 | 23 | 1.180 |
Why?
|
| Mice | 15 | 2023 | 508 | 1.100 |
Why?
|
| Cotinine | 3 | 2020 | 22 | 0.930 |
Why?
|
| Heart | 2 | 2020 | 15 | 0.880 |
Why?
|
| Smoking | 2 | 2020 | 49 | 0.880 |
Why?
|
| Myocardium | 1 | 2020 | 15 | 0.780 |
Why?
|
| Signal Transduction | 5 | 2018 | 180 | 0.760 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 60 | 0.750 |
Why?
|
| Mitochondria | 5 | 2016 | 26 | 0.730 |
Why?
|
| Diet, Western | 1 | 2019 | 7 | 0.700 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 48 | 0.660 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2018 | 6 | 0.650 |
Why?
|
| Benzamides | 1 | 2018 | 13 | 0.650 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2020 | 31 | 0.650 |
Why?
|
| Hepatocytes | 3 | 2014 | 81 | 0.620 |
Why?
|
| Spermatozoa | 5 | 2012 | 9 | 0.580 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2014 | 22 | 0.520 |
Why?
|
| Caspase 2 | 1 | 2014 | 6 | 0.510 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2014 | 46 | 0.500 |
Why?
|
| Muscle, Skeletal | 4 | 2016 | 87 | 0.490 |
Why?
|
| Minocycline | 1 | 2011 | 2 | 0.410 |
Why?
|
| Maternal Exposure | 1 | 2011 | 8 | 0.410 |
Why?
|
| Cocaine | 1 | 2011 | 19 | 0.400 |
Why?
|
| Down-Regulation | 1 | 2011 | 52 | 0.400 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 36 | 0.400 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 12 | 0.370 |
Why?
|
| Immunohistochemistry | 4 | 2019 | 133 | 0.360 |
Why?
|
| Models, Biological | 3 | 2016 | 43 | 0.360 |
Why?
|
| Vaping | 2 | 2019 | 16 | 0.350 |
Why?
|
| Rats | 8 | 2011 | 432 | 0.350 |
Why?
|
| Nicotinic Agonists | 2 | 2019 | 27 | 0.350 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 7 | 0.350 |
Why?
|
| Spermatogenesis | 6 | 2011 | 6 | 0.340 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 143 | 0.340 |
Why?
|
| Mice, Knockout | 6 | 2019 | 112 | 0.340 |
Why?
|
| Blotting, Western | 3 | 2019 | 116 | 0.330 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2020 | 9 | 0.320 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2020 | 22 | 0.320 |
Why?
|
| Chromogranin A | 2 | 2016 | 3 | 0.290 |
Why?
|
| Humans | 7 | 2023 | 2493 | 0.280 |
Why?
|
| Pregnancy | 2 | 2020 | 305 | 0.280 |
Why?
|
| Phosphorylation | 3 | 2016 | 68 | 0.270 |
Why?
|
| Aging | 3 | 2013 | 101 | 0.260 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2023 | 24 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2011 | 179 | 0.240 |
Why?
|
| Triglycerides | 2 | 2014 | 36 | 0.230 |
Why?
|
| Endoribonucleases | 1 | 2023 | 4 | 0.230 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 12 | 0.230 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 12 | 0.230 |
Why?
|
| Female | 3 | 2020 | 1733 | 0.230 |
Why?
|
| Risk Factors | 2 | 2014 | 240 | 0.220 |
Why?
|
| Testis | 6 | 2012 | 16 | 0.220 |
Why?
|
| Cell Differentiation | 2 | 2012 | 79 | 0.210 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 6 | 0.210 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 6 | 0.210 |
Why?
|
| Life Style | 1 | 2021 | 29 | 0.200 |
Why?
|
| Obesity | 2 | 2014 | 102 | 0.200 |
Why?
|
| Diet | 1 | 2021 | 40 | 0.200 |
Why?
|
| Echocardiography | 1 | 2020 | 9 | 0.200 |
Why?
|
| Heart Ventricles | 1 | 2020 | 12 | 0.200 |
Why?
|
| Animals, Newborn | 1 | 2020 | 54 | 0.190 |
Why?
|
| Testosterone | 4 | 2014 | 76 | 0.190 |
Why?
|
| Reproduction | 3 | 2012 | 8 | 0.190 |
Why?
|
| Aerosols | 1 | 2019 | 8 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 7 | 0.180 |
Why?
|
| Stroke Volume | 1 | 2019 | 9 | 0.180 |
Why?
|
| Behavior, Animal | 1 | 2019 | 24 | 0.180 |
Why?
|
| Body Weight | 3 | 2014 | 65 | 0.180 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 12 | 0.180 |
Why?
|
| Random Allocation | 1 | 2019 | 15 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 17 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2019 | 14 | 0.180 |
Why?
|
| Analysis of Variance | 1 | 2019 | 39 | 0.180 |
Why?
|
| Caspases | 2 | 2016 | 21 | 0.170 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2018 | 7 | 0.160 |
Why?
|
| Sertoli Cells | 4 | 2011 | 5 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 5 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 11 | 0.150 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 1 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 2 | 2015 | 9 | 0.150 |
Why?
|
| Insulin Resistance | 1 | 2016 | 44 | 0.150 |
Why?
|
| Chromaffin Granules | 1 | 2015 | 1 | 0.140 |
Why?
|
| Catecholamines | 1 | 2015 | 5 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2015 | 12 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2012 | 29 | 0.130 |
Why?
|
| Dietary Fats | 2 | 2011 | 18 | 0.130 |
Why?
|
| Parabiosis | 1 | 2014 | 2 | 0.130 |
Why?
|
| Muscle Development | 1 | 2014 | 22 | 0.130 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2014 | 4 | 0.120 |
Why?
|
| Lipolysis | 1 | 2014 | 7 | 0.120 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1993 | 16 | 0.120 |
Why?
|
| Pyrazines | 1 | 2014 | 16 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2014 | 42 | 0.120 |
Why?
|
| Sarcopenia | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cystine | 1 | 2013 | 4 | 0.120 |
Why?
|
| Antioxidants | 1 | 2013 | 20 | 0.110 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 10 | 0.110 |
Why?
|
| Animal Feed | 1 | 2012 | 12 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2011 | 24 | 0.110 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2012 | 1 | 0.110 |
Why?
|
| Liver | 1 | 2012 | 120 | 0.110 |
Why?
|
| beta Catenin | 1 | 2011 | 16 | 0.110 |
Why?
|
| Body Composition | 1 | 2011 | 35 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2012 | 41 | 0.100 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 4 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2011 | 7 | 0.100 |
Why?
|
| Fever | 1 | 2008 | 5 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 3 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2008 | 3 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 13 | 0.090 |
Why?
|
| Imidazoles | 1 | 2008 | 16 | 0.090 |
Why?
|
| Pyridines | 1 | 2008 | 22 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 45 | 0.090 |
Why?
|
| Microscopy, Electron | 4 | 2011 | 11 | 0.080 |
Why?
|
| Glucose | 2 | 2016 | 39 | 0.070 |
Why?
|
| WT1 Proteins | 1 | 2006 | 1 | 0.070 |
Why?
|
| Germ Cells | 1 | 2006 | 4 | 0.070 |
Why?
|
| RNA Interference | 1 | 2006 | 9 | 0.070 |
Why?
|
| Apolipoproteins E | 2 | 2019 | 14 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2005 | 2 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2016 | 14 | 0.060 |
Why?
|
| Mutation | 2 | 2019 | 28 | 0.060 |
Why?
|
| Organ Size | 2 | 2014 | 33 | 0.060 |
Why?
|
| Sperm Count | 2 | 1993 | 2 | 0.060 |
Why?
|
| Hep G2 Cells | 1 | 2023 | 6 | 0.060 |
Why?
|
| Palmitates | 1 | 2023 | 5 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2023 | 13 | 0.060 |
Why?
|
| Meiosis | 2 | 2012 | 2 | 0.050 |
Why?
|
| Ribonuclease III | 2 | 2012 | 2 | 0.050 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 6 | 0.050 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 8 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 10 | 0.040 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 17 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 36 | 0.040 |
Why?
|
| Transcriptome | 1 | 2019 | 18 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 1997 | 26 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 2016 | 1 | 0.040 |
Why?
|
| Glycolysis | 1 | 2016 | 4 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 25 | 0.040 |
Why?
|
| Hypophysectomy | 2 | 1993 | 2 | 0.040 |
Why?
|
| Spermatids | 2 | 1993 | 2 | 0.040 |
Why?
|
| Spermatocytes | 2 | 1993 | 2 | 0.040 |
Why?
|
| Exocytosis | 1 | 2015 | 1 | 0.040 |
Why?
|
| Splanchnic Nerves | 1 | 2015 | 1 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2015 | 1 | 0.040 |
Why?
|
| Endocytosis | 1 | 2015 | 2 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2015 | 2 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2015 | 7 | 0.040 |
Why?
|
| Glycogen | 1 | 2015 | 9 | 0.040 |
Why?
|
| Epinephrine | 1 | 2015 | 7 | 0.040 |
Why?
|
| Dopamine | 1 | 2015 | 12 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2015 | 12 | 0.030 |
Why?
|
| Norpregnadienes | 1 | 1995 | 1 | 0.030 |
Why?
|
| Fertility | 1 | 1995 | 3 | 0.030 |
Why?
|
| Progestins | 1 | 1995 | 3 | 0.030 |
Why?
|
| Insulin | 1 | 2015 | 109 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 120 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2014 | 11 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2014 | 8 | 0.030 |
Why?
|
| Inhibins | 1 | 1993 | 1 | 0.030 |
Why?
|
| Leydig Cells | 1 | 1993 | 1 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1993 | 4 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1993 | 3 | 0.030 |
Why?
|
| Kinetics | 1 | 1993 | 44 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 11 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2013 | 119 | 0.030 |
Why?
|
| Haploidy | 1 | 2012 | 1 | 0.030 |
Why?
|
| Protamines | 1 | 2012 | 1 | 0.030 |
Why?
|
| Sperm Head | 1 | 2012 | 1 | 0.030 |
Why?
|
| Ribosomes | 1 | 2012 | 2 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2012 | 10 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 8 | 0.030 |
Why?
|
| Protein Binding | 1 | 2012 | 17 | 0.030 |
Why?
|
| Chromatin | 1 | 2012 | 4 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 62 | 0.030 |
Why?
|
| Base Sequence | 1 | 2012 | 65 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2011 | 7 | 0.030 |
Why?
|
| Energy Intake | 1 | 2011 | 11 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2011 | 1 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2011 | 13 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 28 | 0.030 |
Why?
|
| Adiposity | 1 | 2011 | 18 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2012 | 167 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 93 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 92 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 36 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 5 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2011 | 5 | 0.030 |
Why?
|
| Selenomethionine | 1 | 2011 | 4 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 15 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 30 | 0.030 |
Why?
|
| Pituitary Hormones | 1 | 1991 | 2 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2006 | 1 | 0.020 |
Why?
|
| Gonads | 1 | 2006 | 1 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2006 | 1 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2006 | 1 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2006 | 8 | 0.020 |
Why?
|
| Cell Survival | 1 | 2006 | 17 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 46 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 37 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 52 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 2005 | 3 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2005 | 6 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2005 | 8 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2006 | 42 | 0.020 |
Why?
|
| Gene Expression | 1 | 2006 | 73 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 1997 | 2 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1997 | 14 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1997 | 24 | 0.010 |
Why?
|
| Basement Membrane | 1 | 1991 | 1 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1991 | 1 | 0.010 |
Why?
|
| Sperm Tail | 1 | 1991 | 1 | 0.010 |
Why?
|
| Vacuoles | 1 | 1991 | 1 | 0.010 |
Why?
|
| Biopsy | 1 | 1984 | 16 | 0.000 |
Why?
|
| Cell Count | 1 | 1984 | 10 | 0.000 |
Why?
|